[HTML][HTML] Quantitative proteomic analysis of enhanced cellular effects of electrochemotherapy with Cisplatin in triple-negative breast cancer cells
Due to the lack of the three main receptors, triple negative breast cancer (TNBC) is refractive
to standard chemotherapy. Hence, alternate therapies are needed. TNBCs utilize glycolysis …
to standard chemotherapy. Hence, alternate therapies are needed. TNBCs utilize glycolysis …
Quantitative proteomic analysis of enhanced cellular effects of electrochemotherapy with Cisplatin in triple-negative breast cancer cells.
L Mittal, UK Aryal, IG Camarillo, RM Ferreira… - Scientific …, 2019 - search.ebscohost.com
Due to the lack of the three main receptors, triple negative breast cancer (TNBC) is refractive
to standard chemotherapy. Hence, alternate therapies are needed. TNBCs utilize glycolysis …
to standard chemotherapy. Hence, alternate therapies are needed. TNBCs utilize glycolysis …
Quantitative proteomic analysis of enhanced cellular effects of electrochemotherapy with Cisplatin in triple-negative breast cancer cells.
L Mittal, UK Aryal, IG Camarillo, RM Ferreira… - Scientific …, 2019 - europepmc.org
Due to the lack of the three main receptors, triple negative breast cancer (TNBC) is refractive
to standard chemotherapy. Hence, alternate therapies are needed. TNBCs utilize glycolysis …
to standard chemotherapy. Hence, alternate therapies are needed. TNBCs utilize glycolysis …
Quantitative proteomic analysis of enhanced cellular effects of electrochemotherapy with Cisplatin in triple-negative breast cancer cells
L Mittal, UK Aryal, IG Camarillo, RM Ferreira… - Scientific …, 2019 - ui.adsabs.harvard.edu
Due to the lack of the three main receptors, triple negative breast cancer (TNBC) is refractive
to standard chemotherapy. Hence, alternate therapies are needed. TNBCs utilize glycolysis …
to standard chemotherapy. Hence, alternate therapies are needed. TNBCs utilize glycolysis …
Quantitative proteomic analysis of enhanced cellular effects of electrochemotherapy with Cisplatin in triple-negative breast cancer cells
L Mittal, UK Aryal, IG Camarillo… - Scientific …, 2019 - pubmed.ncbi.nlm.nih.gov
Due to the lack of the three main receptors, triple negative breast cancer (TNBC) is refractive
to standard chemotherapy. Hence, alternate therapies are needed. TNBCs utilize glycolysis …
to standard chemotherapy. Hence, alternate therapies are needed. TNBCs utilize glycolysis …
[HTML][HTML] Quantitative proteomic analysis of enhanced cellular effects of electrochemotherapy with Cisplatin in triple-negative breast cancer cells
L Mittal, UK Aryal, IG Camarillo, RM Ferreira… - Scientific …, 2019 - ncbi.nlm.nih.gov
Due to the lack of the three main receptors, triple negative breast cancer (TNBC) is refractive
to standard chemotherapy. Hence, alternate therapies are needed. TNBCs utilize glycolysis …
to standard chemotherapy. Hence, alternate therapies are needed. TNBCs utilize glycolysis …